Exchange: NASDAQ·Updated 04:21 PM EST

SRTS News

News
all
press releases
Sensus Healthcare (NASDAQ:SRTS) Share Price Crosses Below 50-Day Moving Average Following Weak Earnings
Sensus Healthcare (NASDAQ:SRTS) Share Price Crosses Below 50-Day Moving Average on Disappointing Earnings...
MarketBeat
Sensus Healthcare (NASDAQ:SRTS) Share Price Crosses Below 50-Day Moving Average Following Weak Earnings
Sensus Healthcare (NASDAQ:SRTS) Share Price Crosses Below 50-Day Moving Average on Disappointing Earnings...
MarketBeat
More News
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company committed to providing highly effective, non-invasive treatments for oncological and non-oncological skin conditions, today announced financial results and business highlights for the three months ended September 30, 2026. Highlights...
Business Wire
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company committed to providing highly effective, non-invasive treatments for oncological and non-oncological skin conditions, today announced the sale of its 1,000th superficial radiotherapy (SRT) system, representing an important achievement...
Business Wire
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company committed to providing highly effective, non-invasive treatments for oncological and non-oncological skin conditions, today announced the company will report financial results for the third quarter of 2026 on Thursday, November 12...
Business Wire
Sensus Healthcare (NASDAQ:SRTS) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This content is powered by Benzinga APIs. For comprehensiveread more...
Benzinga
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company committed to providing highly effective, non-invasive treatments for oncological and non-oncological skin conditions, today announced financial results and business highlights for the three months ended June 30, 2026. Highlights...
Business Wire
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company committed to providing highly effective, non-invasive treatments for oncological and non-oncological skin conditions, today announced the company will report financial results for the second quarter of 2026 on Thursday, August 13...
Business Wire
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company committed to providing highly effective, non-invasive treatments for oncological and non-oncological skin conditions, today announced financial results and business highlights for the three months ended March 31, 2026. Highlights...
Business Wire
Sensus Healthcare (NASDAQ:SRTS) will be releasing its Q1 2026 earnings after the market closes on Thursday, May 7. (View Earnings Report at...
MarketBeat

Advertisement|Remove ads.